State Street Corp Humacyte, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Humacyte, Inc. stock. As of the latest transaction made, State Street Corp holds 4,610,496 shares of HUMA stock, worth $16.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,610,496

Previous 4,764,155 3.23%

Holding current value

$16.3 Million

Previous $25.9 Million 10.16%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$3.46 - $5.81 $531,660 - $892,758	-153,659 Reduced 3.23%	4,610,496 $23.3 Million
Q3 2024 Nov 14, 2024	BUY	$5.11 - $9.46 $9.69 Million - $17.9 Million	1,895,529 Added 66.08%	4,764,155 $25.9 Million
Q2 2024 Aug 14, 2024	BUY	$2.87 - $9.1 $4.75 Million - $15.1 Million	1,655,896 Added 136.54%	2,868,626 $13.8 Million
Q1 2024 May 15, 2024	BUY	$2.57 - $4.84 $154,043 - $290,104	59,939 Added 5.2%	1,212,730 $3.77 Million
Q4 2023 Feb 14, 2024	BUY	$1.99 - $3.12 $53,158 - $83,344	26,713 Added 2.37%	1,152,791 $3.27 Million
Q3 2023 Nov 14, 2023	BUY	$2.75 - $4.48 $238,694 - $388,855	86,798 Added 8.35%	1,126,078 $3.3 Million
Q2 2023 Aug 14, 2023	BUY	$2.86 - $4.97 $1.08 Million - $1.88 Million	378,485 Added 57.28%	1,039,280 $2.97 Million
Q1 2023 May 15, 2023	BUY	$2.11 - $3.25 $358,299 - $551,882	169,810 Added 34.59%	660,795 $2.04 Million
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.62 $146,191 - $261,986	72,372 Added 17.29%	490,985 $1.04 Million
Q3 2022 Nov 15, 2022	BUY	$1.22 - $5.14 $696 - $2,934	571 Added 0.14%	418,613 $1.37 Million
Q2 2022 Aug 15, 2022	BUY	$3.21 - $7.86 $567,653 - $1.39 Million	176,839 Added 73.32%	418,042 $1.34 Million
Q1 2022 May 16, 2022	BUY	$4.65 - $7.4 $797,595 - $1.27 Million	171,526 Added 246.17%	241,203 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$7.25 - $11.6 $505,158 - $808,253	69,677 New	69,677 $505,000

Others Institutions Holding HUMA

# of Institutions

172

Shares Held

41M

Call Options Held

553K

Put Options Held

942K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $365M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Humacyte, Inc. Transaction History